Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs

dc.contributor.authorAraújo, Aurigena Antunes de
dc.contributor.authorDantas, Diego de Araújo
dc.contributor.authorNascimento, Gemma Galgani do
dc.contributor.authorRibeiro, Susana Barbosa
dc.contributor.authorChaves, Katarina Melo
dc.contributor.authorSilva, Vanessa de Lima
dc.contributor.authorAraújo Jr., Raimundo Fernandes de
dc.contributor.authorSouza, Dyego Leandro Bezerra de
dc.contributor.authorMedeiros, Caroline Addison Carvalho Xavier de
dc.date.accessioned2018-06-16T12:05:33Z
dc.date.available2018-06-16T12:05:33Z
dc.date.issued2014-05-01
dc.description.resumoThis cross-sectional study compared the effects of treatment with atypical antipsychotic drugs on quality of life (QoL) and side effects in 218 patients with schizophrenia attending the ambulatory services of psychiatric in Rio Grande do Norte, Brazil. Socio-economic variables were compared. The five-dimension EuroQoL (EQ-5D) was used to evaluate QoL, and side effects were assessed using the Udvalg for Kliniske Undersøgelser (UKU) Side Effect Rating Scale and the Simpson–Angus Scale. Data were analysed using the χ 2 test and Student’s t test, with a significance level of 5 %. Average monthly household incomes in the medication groups were 1.1–2.1 minimum wages ($339–$678). UKU Scale scores showed significant differences in side effects, mainly, clozapine, quetiapine and ziprasidone (p < 0.05). EQ-5D scores showed that all drugs except olanzapine significantly impacted mobility (p < 0.05), and proportions of individuals reporting problems in other dimensions were high: 63.6 % of clozapine users reported mobility problems, 63.7 and 56.3 % of clozapine and ziprasidone users, respectively, had difficulties with usual activities, 68.8 and 54.5 % of ziprasidone and clozapine users, respectively, experienced pain and/or discomfort, and 72.8 % of clozapine users reported anxiety and/or depression. Psychiatric, neurological, and autonomous adverse effects, as well as other side effects, were prevalent in users of atypical antipsychotic drugs, especially clozapine and ziprasidone. Olanzapine had the least side effects. QoL was impacted by side effects and economic conditions in all groups. Thus, the effects of these antipsychotic agents appear to have been masked by aggravating social and economic situations.pt_BR
dc.identifier.citationARAÚJO, Aurigena Antunes de et al. Quality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugs. Psychiatric Quarterly, p. 357-67, 2014. Disponível em: <https://link.springer.com/article/10.1007%2Fs11126-014-9290-x>. Acesso em: 19 mar. 2018.pt_BR
dc.identifier.doihttp://dx.doi.org/10.1007/s11126-014-9290-x
dc.identifier.issn1573-6709
dc.identifier.urihttps://repositorio.ufrn.br/jspui/handle/123456789/25424
dc.languageengpt_BR
dc.publisherSpringer Sciencept_BR
dc.rightsAcesso Abertopt_BR
dc.subjectSchizophreniapt_BR
dc.subjectAtypical antipsychoticpt_BR
dc.subjectQuality of lifept_BR
dc.titleQuality of Life in Patients with Schizophrenia: The Impact of Socio-economic Factors and Adverse Effects of Atypical Antipsychotics Drugspt_BR
dc.typearticlept_BR

Arquivos

Pacote Original

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
QualityLifePatients_Araujo_2014.pdf
Tamanho:
315.35 KB
Formato:
Adobe Portable Document Format
Nenhuma Miniatura disponível
Baixar

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Nenhuma Miniatura disponível
Baixar